RDCA-DAP (IMAGE) Critical Path Institute (C-Path) Caption RDCA-DAP is an FDA-funded initiative that will serve as a centralized and standardized base to host and share de-identified rare diseases data and to support treatment innovation. It was created through a partnership between C-Path, NORD® and the FDA and has grown to include many others throughout the rare disease community. Credit C-Path Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.